In the validation cohort, significantly increased levels of ET-1 were confirmed for ME/CFS patients compared to HCs (p = 0.0003, Fig. 3B, Table 2B). The gene discussed is EDN1; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.